Ansa Biotechnologies
Ansa Biotechnologies is hiring a Mechanical Engineer II to support its R&D efforts in enzymatic DNA synthesis. The role is aimed at engineers with 2–4 years of experience who will contribute across the instrument lifecycle and gain hands-on exposure to electromechanical systems, fluidics, and precision motion control. The position emphasizes learning, cross-functional collaboration, and working in a fast-paced, innovative environment.
Headquarters
Emeryville, California, United States
Company Size
11-50 employees
Founded
2018
Ansa Biotechnologies is a synthetic biology company that develops enzymatic DNA synthesis technology for producing high-fidelity, long DNA sequences. Its platform is used to support applications in therapeutics, diagnostics, and biological research.
Ansa Biotechnologies raises $45 million to expand DNA synthesis
Oct 9, 2025
Ansa snares $54.4M in series B financing to boost its DNA synthesis platform
Oct 2, 2025
Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products
Jan 14, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ansa Biotechnologies.
Ending The Waiting Game: How Ansa Biotechnologies Guarantees are Turning DNA Synthesis Into A Predictable Industry
Dec 9, 2025